Trending Stocks : VIVUS Inc. (NASDAQ:VVUS), VeriSign (NASDAQ:VRSN), Oil-Dri Corp. of America (NYSE:ODC), Orbital Sciences Corp. (NYSE:ORB), Telecom Italia S.p.A. (NYSE:TI)

VIVUS, Inc. (NASDAQ:VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update. Total net revenue was $21.9 million for the second quarter of 2014, compared to $5.5 million for the second quarter of 2013. Of the total revenue for the … Continue reading Trending Stocks : VIVUS Inc. (NASDAQ:VVUS), VeriSign (NASDAQ:VRSN), Oil-Dri Corp. of America (NYSE:ODC), Orbital Sciences Corp. (NYSE:ORB), Telecom Italia S.p.A. (NYSE:TI)

Colin Pettis08/0808/08

Hot Movers: Tesla Motors Inc (NASDAQ:TSLA), VIVUS (NASDAQ:VVUS), Teva Pharmaceutical Industries (NYSE:TEVA), Sony (NYSE:SNE), Advanced Micro Devices (NYSE:AMD)

Tesla Motors Inc (NASDAQ:TSLA) hasn’t changed the look of its Model S sedan since the sumptuous electric car first hit the market in 2012. Tesla Motors Inc (NASDAQ:TSLA) stock performance was -0.08% in last session and finished the day at $229.25. Traded volume was 5.17million shares in the last session and the average volume of the stock remained 6.63million shares. The beta of the stock remained … Continue reading Hot Movers: Tesla Motors Inc (NASDAQ:TSLA), VIVUS (NASDAQ:VVUS), Teva Pharmaceutical Industries (NYSE:TEVA), Sony (NYSE:SNE), Advanced Micro Devices (NYSE:AMD)

Colin Pettis07/0707/07

Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

Earlier this month, Vivus Inc. (NASDAQ:VVUS) said it filed a patent-infringement lawsuit against Actavis PLC ( ACT ) alleging that the drug maker’s planned generic version of weight-loss drug Qsymia infringes its patents. VIVUS, Inc. (NASDAQ:VVUS) stock performance was 3.97% in last session and finished the day at $5.50. Traded volume was 4.47million shares in the last session and the average volume of the stock remained 3.04million … Continue reading Health Stocks to Watch: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), MannKind Corporation (NASDAQ:MNKD), Eli Lilly (NYSE:LLY)

John Meady06/2306/23

Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Drugmaker Vivus Inc. (NASDAQ:VVUS) said Thursday it has filed a lawsuit against Actavis PLC and its affiliates in a New Jersey federal court over its bid with the U.S. Food and Drug Administration to sell a generic version of company’ prescription weight-loss drug Qsymia. VIVUS, Inc. (NASDAQ:VVUS) stock performance was -0.19% in last session and finished the day at $5.17. Traded volume was 1.03million shares … Continue reading Hot Watch List: VIVUS (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Biogen Idec Inc (NASDAQ:BIIB)

Mark DeFrance06/1806/18

Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announced that the U.S. Court of Appeals for the Federal Circuit today upheld a ruling by the U.S. District Court for the District of Delaware finding Bristol-Myers Squibb’s entecavir compound claim of U.S. Patent No. 5,206,244 invalid. Teva’s ANDA for entecavir has received tentative approval from the U.S. Food and Drug Administration (FDA). Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) … Continue reading Hot Watch List: Teva Pharmaceutical Industries (NYSE:TEVA), Vodafone Group (NASDAQ:VOD), VIVUS (NASDAQ:VVUS), ConocoPhillips (NYSE:COP), BP plc (ADR) (NYSE:BP)

Kevin Long06/1606/16

Hot Biotech Stocks: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD)

Investment analysts at JPMorgan Chase & Co. dropped their target price on shares of VIVUS (NASDAQ:VVUS) from $8.00 to $5.00 in a note issued to investors on Tuesday, Stock Ratings Network reports. JPMorgan Chase & Co.’s price target would indicate a potential downside of 10.15% from the company’s current price. VIVUS, Inc. (NASDAQ:VVUS)stock performance was 7.23% in last session and finished the day at $ … Continue reading Hot Biotech Stocks: VIVUS, Inc. (NASDAQ:VVUS), Arena Pharmaceuticals (NASDAQ:ARNA), Ariad Pharmaceuticals (NASDAQ:ARIA), Gilead Sciences (NASDAQ:GILD)

Jayne Crisman05/0705/07